{
    "Orphapacket": {
        "ORPHApacketId": "563576",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "563576",
        "Label": "Autoimmune hepatitis type 1",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_563576",
        "DisorderType": {
            "value": "Clinical subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377796"
        },
        "Synonyms": [
            {
                "Synonym": "AIH type 1"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A form of autoimmune hepatitis characterized by clinical presentation as cryptogenic hepatitis interface hepatitis on histological examination elevated serum aminotransferase levels hypergammaglobulinemia/elevated immunoglobulin G and presence of circulating autoantibodies specifically antinuclear antibodies (ANA) anti-smooth muscle antibodies (anti-SMA) and/or anti-soluble liver antigen/liver pancreas antigen antibodies (anti-SLA/LP). The disease predominantly develops at a post-pubertal age and most commonly takes a chronic course although acute or acute severe presentation may also be observed. Typical concurrent autoimmune diseases are autoimmune thyroiditis and rheumatic diseases."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "2137",
                        "Label": "Autoimmune hepatitis"
                    }
                ]
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        }
    }
}